ALFA Finder| Execution period | Mr. Sanjeev Kumar (CFO) and Mr. Rajiv Maliwal (Independent Director) terms commence May 25, 2026. |
|---|
BSE filing, NSE: HCG. Summary written from the filing by ALFA Finder's alert engine.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹568.85
- Market cap
- ₹8,493 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 751.6×Sector 54.5×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Earnings Call Transcript: Key Takeaways
Q2 revenue ₹732 Cr, +16% YoY; H1 ₹1,410 Cr, +15%. EBITDA margin 19.7% despite ~₹6 Cr wage-revision hit. Trade-margin cap guided at mid-to-high single-digit annualised impact, with few specifics.
Healthcare Global Enterprises Results Update
HCG reported Q2 FY27 revenue of INR 7,318 Mn, up 16% YoY, with adjusted EBITDA up 17%. Results cover the quarter and half-year ended September 30, 2026.
Healthcare Global Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 7,318 Mn (+16% YoY) and Adjusted EBITDA INR 1,425 Mn (+17%, 19.7% margin). Reported PAT INR 92.5 Mn. Plan to add 1,000 beds by FY30.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Healthcare Global Enterprises Q2 FY27 Results: Net Profit ₹9.2 Cr, Down 55.6% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹731.8 Cr (+13.1% YoY) and net profit of ₹9.2 Cr (-55.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.2 Cr · -55.6% YoY
Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Other management change announcements
All →Aspire & Innovative Advertising Management Change
Aspire & Innovative Advertising accepted resignation of Independent Director Sudhanshu Singhal and appointed Ms. Pankila as Additional Director. The board confirmed both changes on November 12, 2026.
Liqvd Digital India Management Change
Liqvd Digital India's MD Arnab Mitra will not seek re-appointment, ceasing as MD from 8 December 2026. The Board will expedite identifying a successor.
Brand Concepts Management Change
Brand Concepts Limited announced the cessation of Independent Director Narender Tulsiidas Kabra due to expiry of term. The departure is effective 5 November 2026.
5Paisa Capital Management Change
5Paisa Capital appointed Ms. Devi Yesodharan as Chief Content and Research Officer effective November 13, 2026. She brings 21+ years of experience from Trendlyne, Infosys, and other firms to the Senior Management role.
Magnum Ventures Management Change
Magnum Ventures' General Manager, Business Development (Hotel Unit), Ms. Sukhpreet Kaur Bedi, resigned effective November 6, 2026. The senior-management departure was disclosed under SEBI Regulation 30.
LGT Global Hospitality Management Change
LGT Global Hospitality's Company Secretary Ms. Ankita Jain resigned effective 15 Nov 2026. Ms. Dharshini S was appointed to the role w.e.f. 16 Nov 2026.